Section Arrow
SNN.NYSE
- Smith & Nephew plc
Quotes are at least 15-min delayed:2026/06/21 09:53 EDT
Regular Hours
Last
 30.08
+0.01 (+0.03%)
Day High 
30.235 
Prev. Close
30.07 
1-M High
31.4 
Volume 
1.05M 
Bid
26
Ask
31
Day Low
29.76 
Open
29.79 
1-M Low
29.12 
Market Cap 
12.74B 
Currency 美元 
P/E 21.01 
%Yield 2.6 
10-SMA 30.63 
20-SMA 30.37 
50-SMA 31.17 
52-W High 38.79 
52-W Low 28.8 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
1.43/2.41
Enterprise Value
15.92B
Balance Sheet
Book Value Per Share
12.49
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
3.96B
Operating Revenue Per Share
12.63
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BFLYButterfly Network8.9+3.19+55.87%-- 
ABTAbbott Laboratories88.41-0.09-0.10%24.76PE
TNONTenon Medical Inc0.35-0.2521-41.87%-- 
BSXBoston Scientific Corp45.29+0.34+0.76%18.95PE
MDTMedtronic plc79.34+1.2+1.54%22.16PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.